| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.32▼ | 5.31▼ | 5.31▼ | 5.20▲ | 5.39▼ |
| MA10 | 5.32▼ | 5.31▼ | 5.29▲ | 5.15▲ | 5.83▼ |
| MA20 | 5.32▼ | 5.28▲ | 5.20▲ | 5.34▼ | 6.51▼ |
| MA50 | 5.28▲ | 5.22▲ | 5.23▲ | 6.09▼ | 8.16▼ |
| MA100 | 5.21▲ | 5.19▲ | 5.21▲ | 6.67▼ | 11.74▼ |
| MA200 | 5.24▲ | 5.29▲ | 5.58▼ | 8.07▼ | 17.72▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.005▲ | 0.015▲ | 0.053▲ | -0.086▼ |
| RSI | 50.314▲ | 54.704▲ | 54.612▲ | 44.950▼ | 37.918▼ |
| STOCH | 76.190 | 42.181 | 45.488 | 45.659 | 11.016▼ |
| WILL %R | -46.667 | -59.259 | -43.636 | -55.435 | -88.916▼ |
| CCI | -57.427 | 40.497 | 54.110 | 38.963 | -93.990 |
|
Friday, June 12, 2026 06:00 AM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
|
Thursday, April 30, 2026 08:05 AM
Detailed price information for Aligos Therapeutics Inc (ALGS-Q) from The Globe and Mail including charting and trades.
|
|
Friday, April 24, 2026 01:00 AM
SOUTH SAN FRANCISCO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/06/26 | 5.25 | 5.42 | 5.1578 | 5.28 | 37,192 |
| 17/06/26 | 5.07 | 5.73 | 5.07 | 5.35 | 155,331 |
| 16/06/26 | 5.08 | 5.12 | 4.98 | 4.99 | 39,558 |
| 15/06/26 | 5.30 | 5.40 | 5.10 | 5.11 | 86,797 |
| 12/06/26 | 5.20 | 5.55 | 5.20 | 5.28 | 76,676 |
| 11/06/26 | 5.13 | 5.43 | 4.91 | 5.28 | 49,730 |
| 10/06/26 | 5.12 | 5.31 | 5.07 | 5.16 | 31,973 |
| 09/06/26 | 5.05 | 5.29 | 4.985 | 5.14 | 81,099 |
| 08/06/26 | 5.01 | 5.05 | 4.91 | 4.96 | 64,978 |
| 05/06/26 | 5.30 | 5.3359 | 4.82 | 4.91 | 127,709 |
|
|
||||
|
|
||||
|
|